Pfizer, Inc. · NYSE:PFE
Pfizer — 30th Annual J.P. Morgan Healthcare Conference (January 2012)
7 slides from Pfizer's conference presentation, Jan 10, 2012
Slide 1: J.P. Morgan Healthcare Conference
J.P. Morgan Healthcare Conference Ian Read Chairman and Chief Executive Officer January 10, 2012
Slide 2: Forward-Looking Statements and Non-GAAP Financial Information
Forward-Looking Statements and Non-GAAP Financial Information ● Our discussions during this conference will include forward-looking statements. Actual results could differ materially from those projected in the forward-looking statements. The factors that could cause actual results to differ are dis
Slide 3: Improving the Performance of the Innovative Core: Sustainable Pipeline Engine
Improving the Performance of the Innovative Core “Sustainable Pipeline Engine” Capitalize Advance Develop on Near-Term Opportunities the Late-Stage Pipeline the Next Wave of Compounds TM Prevnar 13 for Adults Dacomitinib (Lung Cancer) PCSK9 (Hyperlipidemia) Tofacitinib (RA) Inotuzumab (Lym
Slide 4: Improving the Rigor and Productivity of R&D
Improving the Rigor and Productivity of R&D ● Focusing on therapeutic areas where we believe we have the right elements for success Neuroscience, CVMED, Oncology, Inflammation and Immunology, Vaccines, Pain and Sensory Disorders and Biosimilars ● Prioritizing the R&D portfolio Terminated over 90
Slide 5: CEO Perspectives on Enhanced Shareholder Value in 2011
CEO Perspectives on Enhanced Shareholder Value in 2011 ● Shareholder-focused capital allocation decisions taken during 2011 Returned $15 billion to shareholders through dividends and share repurchases Announced 10% dividend increase for first quarter 2012 Authorized a new share repurchase prog
Slide 6: Focus in 2012
Focus in 2012 ● Continued pipeline advancement including several product launches ● Continued strengthening of our Emerging Markets business ● Optimizing our Established Products business and deploying its cash flow in the best interests of shareholders ● Clarity regarding next steps for the potenti
Slide 7: Q&A Session
J.P. Morgan Healthcare Conference Q&A Session January 10, 2012
Pfizer — 30th Annual J.P. Morgan Healthcare Conference (January 2012) on 6ix